{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:23:09Z","timestamp":1791062589495,"version":"4.1.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":942,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Collectively, the data in both humans and murine models of human primary biliary cirrhosis (PBC) suggest that activated T cells, particularly CD8 T cells, play a critical role in biliary cell destruction. Under physiological conditions, T-cell activation involves two critical signals that involve the major histocompatibility complex and a set of costimulatory molecules, which include a receptor on T cells termed cytotoxic T lymphocyte antigen 4 (CTLA-4). Germane to the studies reported herein, signaling by CTLA-4 has the potential to modulate costimulation and induce inhibitory signals. In this study, we have taken advantage of our well-defined murine model of PBC, in which mice are immunized with 2-octynoic acid coupled to bovine serum albumin (2OA-BSA), leading to the production of high-titer antimitochondrial autoantibodies (AMAs) and portal cellular infiltrates. To investigate the potential of CTLA-4-Ig (immunoglobulin) as an immunotherapeutic agent, we treated mice both before and after induction of autoimmune cholangitis. First, we demonstrate that CTLA-4-Ig treatment, begun 1 day before 2OA-BSA immunization, completely inhibits the manifestations of cholangitis, including AMA production, intrahepatic T-cell infiltrates, and bile duct damage. However, and more critically, treatment with CTLA-4-Ig, initiated after the development of autoimmune cholangitis in previously immunized mice, also resulted in significant therapeutic benefit, including reduced intrahepatic T-cell infiltrates and biliary cell damage, although AMA levels were not altered.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>These data suggest that an optimized regimen with CTLA-4-Ig has the potential to serve as an investigative therapeutic tool in patients with PBC.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26067","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T16:37:19Z","timestamp":1348072639000},"page":"708-715","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":91,"title":["Therapeutic Effect of Cytotoxic T Lymphocyte Antigen 4\/Immunoglobulin on a Murine Model of Primary Biliary Cirrhosis"],"prefix":"10.1097","volume":"57","author":[{"given":"Amy","family":"Dhirapong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Xiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weici","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tsuneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Knechtle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab A.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross L.","family":"Coppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Song","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-30-20241201","doi-asserted-by":"crossref","first-page":"210225","DOI":"10.1034\/j.1600-0528.2002.017402.x","article-title":"Primary biliary cirrhosis: an orchestrated immune response against epithelial cells.","volume":"174","author":"Gershwin","year":"2000","journal-title":"Immunol Rev"},{"key":"R2-30-20241201","doi-asserted-by":"crossref","first-page":"113123","DOI":"10.1084\/jem.20010956","article-title":"Identification of HLAA2restricted CD8() cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes crosspresented by dendritic cells.","volume":"195","author":"Kita","year":"2002","journal-title":"J Exp Med"},{"key":"R3-30-20241201","doi-asserted-by":"crossref","first-page":"12311240","DOI":"10.1172\/JCI0214698","article-title":"Quantitative and functional analysis of PDCE2specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis.","volume":"109","author":"Kita","year":"2002","journal-title":"Journal Clin Invest"},{"key":"R4-30-20241201","doi-asserted-by":"crossref","first-page":"18311840","DOI":"10.1172\/JCI4213","article-title":"Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis.","volume":"102","author":"Shimoda","year":"1998","journal-title":"J Clin Invest"},{"key":"R5-30-20241201","doi-asserted-by":"crossref","first-page":"19741982","DOI":"10.1002\/hep.22226","article-title":"Adoptive transfer of CD8() T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.","volume":"47","author":"Yang","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R6-30-20241201","doi-asserted-by":"crossref","first-page":"12591267","DOI":"10.4049\/jimmunol.1001597","article-title":"CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease.","volume":"186","author":"Yang","year":"2011","journal-title":"J Immunol"},{"key":"R7-30-20241201","doi-asserted-by":"crossref","first-page":"531540","DOI":"10.1002\/hep.22390","article-title":"Loss of tolerance in C57BL6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease.","volume":"48","author":"Wakabayashi","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R8-30-20241201","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1016\/1074-7613(95)90161-2","article-title":"CD28 costimulation can promote T cell survival by enhancing the expression of BclXL.","volume":"3","author":"Boise","year":"1995","journal-title":"Immunity"},{"key":"R9-30-20241201","doi-asserted-by":"crossref","first-page":"501508","DOI":"10.1016\/1074-7613(94)90092-2","article-title":"Absence of B7dependent responses in CD28deficient mice.","volume":"1","author":"Green","year":"1994","journal-title":"Immunity"},{"key":"R10-30-20241201","doi-asserted-by":"crossref","first-page":"51385142","DOI":"10.1073\/pnas.91.11.5138","article-title":"Costimulator B71 confers antigenpresentingcell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice.","volume":"91","author":"Guerder","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R11-30-20241201","doi-asserted-by":"crossref","first-page":"11341142","DOI":"10.1038\/ni1124","article-title":"CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86.","volume":"5","author":"Orabona","year":"2004","journal-title":"Nat Immunol"},{"key":"R12-30-20241201","first-page":"4146","article-title":"T cell costimulation through the CD28 receptor.","volume":"107","author":"Green","year":"1995","journal-title":"Proc Assoc Am Physicians"},{"key":"R13-30-20241201","doi-asserted-by":"crossref","first-page":"759762","DOI":"10.1084\/jem.173.3.759","article-title":"The CD28 ligand B7BB1 provides costimulatory signal for alloactivation of CD4 T cells.","volume":"173","author":"Koulova","year":"1991","journal-title":"J Exp Med"},{"key":"R14-30-20241201","doi-asserted-by":"crossref","first-page":"721730","DOI":"10.1084\/jem.173.3.721","article-title":"Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.","volume":"173","author":"Linsley","year":"1991","journal-title":"J Exp Med"},{"key":"R15-30-20241201","doi-asserted-by":"crossref","first-page":"229237","DOI":"10.1172\/JCI115840","article-title":"The B7BB1 antigen provides one of several costimulatory signals for the activation of CD4 T lymphocytes by human blood dendritic cells in vitro.","volume":"90","author":"Young","year":"1992","journal-title":"J Clin Invest"},{"key":"R16-30-20241201","doi-asserted-by":"crossref","first-page":"201210","DOI":"10.1016\/S1074-7613(02)00362-X","article-title":"The interaction properties of costimulatory molecules revisited.","volume":"17","author":"Collins","year":"2002","journal-title":"Immunity"},{"key":"R17-30-20241201","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1600-065X.2009.00784.x","article-title":"Mechanisms of costimulation.","volume":"229","author":"Sharpe","year":"2009","journal-title":"Immunol Rev"},{"key":"R18-30-20241201","first-page":"180205","article-title":"Intrinsic and extrinsic control of peripheral Tcell tolerance by costimulatory molecules of the CD28 B7 family.","volume":"241","author":"BourJordan","year":"2011","journal-title":"Immunol Rev"},{"key":"R19-30-20241201","doi-asserted-by":"crossref","first-page":"428433","DOI":"10.1016\/j.it.2011.06.002","article-title":"Cellautonomous and nonautonomous roles of CTLA4 in immune regulation.","volume":"32","author":"Wing","year":"2011","journal-title":"Trends Immunol"},{"key":"R20-30-20241201","doi-asserted-by":"crossref","first-page":"267270","DOI":"10.1038\/328267a0","article-title":"A new member of the immunoglobulin superfamilyCTLA4.","volume":"328","author":"Brunet","year":"1987","journal-title":"Nature"},{"key":"R21-30-20241201","doi-asserted-by":"crossref","first-page":"220228","DOI":"10.1038\/35105024","article-title":"Tcell regulation by CD28 and CTLA4.","volume":"1","author":"Alegre","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"R22-30-20241201","doi-asserted-by":"crossref","first-page":"2676226771","DOI":"10.1074\/jbc.271.43.26762","article-title":"Covalent dimerization of CD28CTLA4 and oligomerization of CD80CD86 regulate T cell costimulatory interactions.","volume":"271","author":"Greene","year":"1996","journal-title":"J Biol Chem"},{"key":"R23-30-20241201","doi-asserted-by":"crossref","first-page":"459465","DOI":"10.1084\/jem.182.2.459","article-title":"CD28 and CTLA4 have opposing effects on the response of T cells to stimulation.","volume":"182","author":"Krummel","year":"1995","journal-title":"J Exp Med"},{"key":"R24-30-20241201","doi-asserted-by":"crossref","first-page":"793801","DOI":"10.1016\/S1074-7613(94)80021-9","article-title":"Human B71 (CD80) and B72 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA4 receptors.","volume":"1","author":"Linsley","year":"1994","journal-title":"Immunity"},{"key":"R25-30-20241201","doi-asserted-by":"crossref","first-page":"541547","DOI":"10.1016\/1074-7613(95)90125-6","article-title":"Loss of CTLA4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA4.","volume":"3","author":"Tivol","year":"1995","journal-title":"Immunity"},{"key":"R26-30-20241201","doi-asserted-by":"crossref","first-page":"405413","DOI":"10.1016\/1074-7613(94)90071-X","article-title":"CTLA4 can function as a negative regulator of T cell activation.","volume":"1","author":"Walunas","year":"1994","journal-title":"Immunity"},{"key":"R27-30-20241201","doi-asserted-by":"crossref","first-page":"26512657","DOI":"10.4049\/jimmunol.179.4.2651","article-title":"Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization.","volume":"179","author":"Leung","year":"2007","journal-title":"J Immunol"},{"key":"R28-30-20241201","doi-asserted-by":"crossref","first-page":"577586","DOI":"10.1111\/j.1365-2249.2008.03837.x","article-title":"Induction of autoimmune cholangitis in nonobese diabetic (NOD).1101 mice following a chemical xenobiotic immunization.","volume":"155","author":"Wakabayashi","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"R29-30-20241201","first-page":"S30S34","article-title":"Efficacy results from pivotal clinical trials with abatacept.","volume":"25","author":"Rozelle","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"R30-30-20241201","doi-asserted-by":"crossref","first-page":"12451254","DOI":"10.1517\/14712598.5.9.1245","article-title":"Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis.","volume":"5","author":"Teng","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"R31-30-20241201","first-page":"22042210","article-title":"Abatacept binds to the Fc receptor CD64 but does not mediate complementdependent cytotoxicity or antibodydependent cellular cytotoxicity.","volume":"34","author":"Davis","year":"2007","journal-title":"J Rheumatol"},{"key":"R32-30-20241201","doi-asserted-by":"crossref","first-page":"16551660","DOI":"10.4049\/jimmunol.177.3.1655","article-title":"Antimitochondrial antibodies and primary biliary cirrhosis in TGFbeta receptor II dominantnegative mice.","volume":"177","author":"Oertelt","year":"2006","journal-title":"J Immunol"},{"key":"R33-30-20241201","doi-asserted-by":"crossref","first-page":"987998","DOI":"10.1002\/hep.23783","article-title":"Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis.","volume":"52","author":"Lleo","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R34-30-20241201","doi-asserted-by":"crossref","first-page":"110120","DOI":"10.1111\/j.1365-2249.2011.04453.x","article-title":"The multihit hypothesis of primary biliary cirrhosis: polyinosinicpolycytidylic acid (poly I:C) and murine autoimmune cholangitis.","volume":"166","author":"Ambrosini","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"R35-30-20241201","doi-asserted-by":"crossref","first-page":"38153825","DOI":"10.1182\/blood.V83.12.3815.3815","article-title":"In vivo blockade of CD28CTLA4: B7BB1 interaction with CTLA4Ig reduces lethal murine graftversushost disease across the major histocompatibility complex barrier in mice.","volume":"83","author":"Blazar","year":"1994","journal-title":"Blood"},{"key":"R36-30-20241201","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.clim.2007.08.019","article-title":"Abatacept modulates human dendritic cellstimulated Tcell proliferation and effector function independent of IDO induction.","volume":"126","author":"Davis","year":"2008","journal-title":"Clin Immunol"},{"key":"R37-30-20241201","first-page":"267276","article-title":"CTLA4Ig and the therapeutic potential of T cell costimulation blockade.","volume":"33","author":"Graca","year":"2008","journal-title":"Acta Reumatol Port"},{"key":"R38-30-20241201","doi-asserted-by":"crossref","first-page":"383391","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, doubleblind, placebocontrolled withdrawal trial.","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"key":"R39-30-20241201","doi-asserted-by":"crossref","first-page":"17921802","DOI":"10.1002\/art.27431","article-title":"Longterm safety and efficacy of abatacept in children with juvenile idiopathic arthritis.","volume":"62","author":"Ruperto","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R40-30-20241201","doi-asserted-by":"crossref","first-page":"987993","DOI":"10.1172\/JCI118146","article-title":"Collageninduced arthritis in the BB rat. Prevention of disease by treatment with CTLA4Ig.","volume":"96","author":"Knoerzer","year":"1995","journal-title":"J Clin Invest"},{"key":"R41-30-20241201","doi-asserted-by":"crossref","first-page":"27832789","DOI":"10.1172\/JCI117982","article-title":"Longterm inhibition of murine experimental autoimmune encephalomyelitis using CTLA4Fc supports a key role for CD28 costimulation.","volume":"95","author":"Cross","year":"1995","journal-title":"J Clin Invest"},{"key":"R42-30-20241201","doi-asserted-by":"crossref","first-page":"939948","DOI":"10.1002\/art.30176","article-title":"Abatacept in the treatment of patients with psoriatic arthritis: results of a sixmonth, multicenter, randomized, doubleblind, placebocontrolled, phase II trial.","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R43-30-20241201","doi-asserted-by":"crossref","first-page":"30773087","DOI":"10.1002\/art.27601","article-title":"The efficacy and safety of abatacept in patients with nonlifethreatening manifestations of systemic lupus erythematosus: results of a twelvemonth, multicenter, exploratory, phase IIb, randomized, doubleblind, placebocontrolled trial.","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R44-30-20241201","doi-asserted-by":"crossref","first-page":"11081110","DOI":"10.1136\/ard.2010.145946","article-title":"Treatment of active ankylosing spondylitis with abatacept: an openlabel, 24week pilot study.","volume":"70","author":"Song","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R45-30-20241201","doi-asserted-by":"crossref","first-page":"33823391","DOI":"10.4049\/jimmunol.169.6.3382","article-title":"Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NFkappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4Ig.","volume":"169","author":"Bonham","year":"2002","journal-title":"J Immunol"},{"key":"R46-30-20241201","doi-asserted-by":"crossref","first-page":"199204","DOI":"10.1084\/jem.188.1.199","article-title":"Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28deficient mice: CTLA4 can function independently of CD28.","volume":"188","author":"Lin","year":"1998","journal-title":"J Exp Med"},{"key":"R47-30-20241201","doi-asserted-by":"crossref","first-page":"205212","DOI":"10.1016\/S0039-6060(96)80289-3","article-title":"Longterm survival of rat to mouse cardiac xenografts with prolonged blockade of CD28B7 interaction combined with peritransplant Tcell depletion.","volume":"120","author":"Rehman","year":"1996","journal-title":"Surgery"},{"key":"R48-30-20241201","doi-asserted-by":"crossref","first-page":"10481055","DOI":"10.2337\/diabetes.54.4.1048","article-title":"Achieving permanent survival of islet xenografts by independent manipulation of direct and indirect Tcell responses.","volume":"54","author":"Mirenda","year":"2005","journal-title":"Diabetes"},{"key":"R49-30-20241201","doi-asserted-by":"crossref","first-page":"686694","DOI":"10.4049\/jimmunol.170.2.686","article-title":"Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses.","volume":"170","author":"Tangye","year":"2003","journal-title":"J Immunol"},{"key":"R50-30-20241201","doi-asserted-by":"crossref","first-page":"1342013425","DOI":"10.1073\/pnas.0703872104","article-title":"Decreased expression of Kruppellike factors in memory B cells induces the rapid response typical of secondary antibody responses.","volume":"104","author":"Good","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R51-30-20241201","doi-asserted-by":"crossref","first-page":"215222","DOI":"10.1002\/hep.23664","article-title":"Deletion of interleukin6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.","volume":"52","author":"Zhang","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R52-30-20241201","doi-asserted-by":"crossref","first-page":"14941500","DOI":"10.1002\/hep.23132","article-title":"Deletion of interleukin12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.","volume":"50","author":"Yoshida","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R53-30-20241201","doi-asserted-by":"crossref","first-page":"261267","DOI":"10.1111\/j.1365-2249.2012.04577.x","article-title":"Epitopespecific antinuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokinedependent.","volume":"168","author":"Yang","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"R54-30-20241201","doi-asserted-by":"crossref","first-page":"122139","DOI":"10.1111\/j.1600-065X.2012.01136.x","article-title":"Immune checkpoints in central nervous system autoimmunity.","volume":"248","author":"Joller","year":"2012","journal-title":"Immunol Rev"},{"key":"R55-30-20241201","doi-asserted-by":"crossref","first-page":"12201227","DOI":"10.1136\/ard.2008.091876","article-title":"Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study.","volume":"68","author":"Buch","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R56-30-20241201","first-page":"510518","article-title":"Selective modulation of Tcell costimulation: a novel mode of action for the treatment of rheumatoid arthritis.","volume":"27","author":"Choy","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"R57-30-20241201","doi-asserted-by":"crossref","first-page":"437449","DOI":"10.1093\/rheumatology\/keq287","article-title":"Abatacept treatment for rheumatoid arthritis.","volume":"50","author":"Schiff","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R58-30-20241201","doi-asserted-by":"crossref","first-page":"233238","DOI":"10.1016\/j.immuni.2006.03.001","article-title":"CTLA4Ig: bridging the basic immunology with clinical application.","volume":"24","author":"Bluestone","year":"2006","journal-title":"Immunity"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26067","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201302000-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:06:44Z","timestamp":1733062004000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201302000-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26067","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}